Alternatives to Iambic Therapeutics

AI drug discovery from Isomorphic Labs: predictive and generative models that design molecules and forecast drug performance.

Generative AI drug discovery suite spanning target ID, molecule design, biologics and clinical trial prediction.

AI drug discovery driven by a wet-and-dry lab-in-the-loop that runs millions of weekly cell experiments.

Xaira Therapeutics pairs causal perturbation AI models with agentic and robotic labs to discover and validate new medicines

Physics-based molecular simulation and AI for drug discovery and materials design.

AI-native drug discovery company pairing 20+ petabytes of cellular data with human genetics to find causal disease targets

BenevolentAI applies a decade-built biomedical knowledge graph to drug target discovery and repurposing for biopharma R&D teams.

Owkin pairs K Pro, an autonomous AI scientist, with 25 million patients' data across 840 hospitals and wet lab validation for drug R&D

Delineate assembles clinical pharmacology evidence into MBMA databases and models for dose optimization and go/no-go decisions.

Nimbus Therapeutics designs highly selective small-molecule drugs for oncology, immunology, and metabolic disease.

Evotec is a life-science partner running AI-assisted drug discovery and Just–Evotec Biologics manufacturing.

Proton powers AI-first medicinal chemistry and synthesis-aware molecule design for partnered drug discovery programs.

Open-source, self-hosted AI research assistant for drug discovery — molecular property prediction, virtual screening and PK/PD modeling on your own hardware.

SciSpace BioMed Agent runs multi-omics, variant prioritization, and drug repurposing analysis from plain-language biomedical prompts.

Open-source Python framework that assembles causal and mechanistic models from literature and biological databases.

Iktos pairs generative AI for small-molecule design with AI retrosynthesis and an autonomous robotic DMTA lab.

AI-native pharma company using autonomous agents to find new uses for existing drugs and predict patient drug response

HealthKey uses AI patient identification to scan your EHR daily and surface trial-eligible patients for clinical research.

Frekils is AI agents for real-world evidence studies — cohorts, SAPs and publication-ready statistics on your own clinical data.

AI-CRISPR target discovery platform pairing AlgenCRISPR gene modulation with the AlgenBrain foundation model for causal immunology and

Clinician-centered clinical trial matching that notifies your patients when a local, medically relevant study exists.

A research-stage AI platform for discovering neurotherapeutics that act on neural circuits across multiple disorders.

Atomwise runs AI virtual screening of chemical space to surface novel small-molecule drug candidates for immune and inflammatory disease

Cloud R&D platform combining ELN, LIMS, automation, and agent-driven Science Foundries for biotech.

Enterprise scientific intelligence platform whose Luma Agent plans, runs and documents R&D data analysis under human approval

AI protein engineering platform that designs optimized variant plates and learns from every wet-lab round.

NovaFlow is an AI data analyst for biology labs that turns raw sequencing output into cited, publication-ready results.

Cellbyte gives pharma Pricing & Market Access teams source-linked HTA and pricing answers in minutes, not weeks.

Oncology real-world evidence built from point-of-care data, with AI-driven insights across a global database of six million+ patients.

Cellino's AI-guided optical bioprocessing platform brings patient-specific cell therapy manufacturing to the hospital.